Showing results (11-20 of 166) with videos related to
Sort By:
Pageof 17
Seminars in Oncology|May 29, 1999
Pharmacoeconomics of amifostine in ovarian cancerE A Calhoun, C L BennettCancer Investigation|April 9, 2001
Quality improvement efforts in oncology: are we ready to begin?C L Bennett, J M Crane, Current Opinion in Pediatrics|December 26, 2001
IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomenaC L Bennett, H D OchsAnnals of Internal Medicine|February 1, 1992
Granulocyte-macrophage colony-stimulating factor (GM-CSF) as adjunct therapy in relapsed Hodgkin diseaseS C Gulati, C L BennettOncology (Williston Park, N.Y.)|November 1, 1995
Economic analysis during phase III clinical trials: who, what, when, where, and why?C L Bennett, I L WestermanClinical Performance and Quality Health Care|June 7, 1995
Cost-effectiveness models of clinical trials of new pharmaceuticals for AIDS-related Pneumocystis carinii pneumonia: are they helpful to policy makers?C L Bennett, E Oddone, D MatcharAmerican Journal of Primatology|May 29, 2001
Abundance, diversity, and patterns of distribution of primates on the Tapiche River in Amazonian PeruC L Bennett, S Leonard, S CarterJournal of Acquired Immune Deficiency Syndromes|January 1, 1991
The costs of AIDS in Los AngelesC L Bennett, M Cvitanic, A PascalOncology (Williston Park, N.Y.)|January 16, 1998
Variations in the use of prostate cancer staging tests: results from one NCCN InstitutionC L Bennett, T Yang, R NadlerExpert Opinion on Pharmacotherapy|May 5, 2001
Pricing, profits and pharmacoeconomics--for whose benefit?J R Adams, S Ali, C L BennettPageof 17